首页> 美国卫生研究院文献>High-Throughput >Protein Adductomics: Methodologies for Untargeted Screening of Adducts to Serum Albumin and Hemoglobin in Human Blood Samples
【2h】

Protein Adductomics: Methodologies for Untargeted Screening of Adducts to Serum Albumin and Hemoglobin in Human Blood Samples

机译:蛋白质成瘾术:人体血液样品中血清白蛋白和血红蛋白加合物的非靶向筛选方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, hemoglobin (Hb), and human serum albumin (HSA), in human blood samples. During the last decade, methods for untargeted screening of such adducts, called “adductomics”, have used liquid chromatography-mass spectrometry to detect large numbers of previously unknown Hb and HSA adducts. This review presents methodologies that were developed and used in our laboratories for Hb and HSA adductomics, respectively. We discuss critical aspects regarding choice of target protein, sample preparation, mass spectrometry, data evaluation, and strategies for identification of detected unknown adducts. With this review we give an overview of these two methodologies used for protein adductomics and the precursor electrophiles that have been elucidated from the adducts.
机译:亲电子试剂在体内的反应产物可以作为人体血液样品中丰富的蛋白质,血红蛋白(Hb)和人体血清白蛋白(HSA)的加合物进行测量。在过去十年中,用于这类加合物的非目标筛选的方法称为“加合物组学”,已使用液相色谱-质谱法检测大量先前未知的Hb和HSA加合物。这篇综述介绍了我们实验室中分别针对Hb和HSA原子疗法开发和使用的方法。我们讨论了有关靶蛋白选择,样品制备,质谱分析,数据评估以及鉴定未知加合物的策略的关键方面。通过这篇综述,我们对蛋白质加成药物学和从加合物中阐明的前体亲电试剂的这两种方法进行了概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号